Emerging Biotech Leader TrueBinding, a clinical-stage biotherapeutic company focusing on Dementia and Alzheimer's Disease treatments, presents a valuable opportunity for partnership and collaboration in the rapidly growing biotechnology sector.
Innovative Technology Integration By leveraging a tech stack including Wix, Squarespace Commerce, and Google Font API, TrueBinding demonstrates a commitment to innovation and digital presence, signaling readiness for potential tech-driven solutions and enhancements.
Revenue Growth Potential With reported revenue reaching $10M - 50M, TrueBinding showcases significant growth potential, making it an attractive prospect for investors and partners seeking opportunities in the biotechnology research space.
Strategic Location Advantage Situated in Foster City, CA, a hub for biotechnology and healthcare innovation, TrueBinding benefits from a strategic location conducive to networking, partnerships, and access to top talent in the industry.
Focused Research Portfolio Specializing in monoclonal antibody drugs for neurodegenerative diseases, TrueBinding's research focus on Dementia and Alzheimer's Disease presents a unique market positioning, offering tailored solutions and differentiation in the competitive landscape.
874
$50M$100M
1K$100M$1B
1.5K$100M$1B
103TrueBinding uses 8 technology products and services including Wix, Squarespace Commerce, Google Font API, and more. Explore TrueBinding's tech stack below.
| TrueBinding Email Formats | Percentage |
| FLast@truebinding.com | 50% |
| FLast@truebinding.com | 50% |
Biotechnology ResearchCalifornia, United States51-200 Employees
Founded in 2016, TrueBinding Inc. is a clinical-stage biotherapeutic company researching and developing first-in-class monoclonal antibody drugs to treat Dementia and Alzheimer's Disease (AD).
Company Overview
Funding & FinancialsTrueBinding's revenue is in the range of $10M$50M
Funding & FinancialsTrueBinding's revenue is in the range of $10M$50M
1-888-653-2347 
support@leadiq.com